Literature DB >> 15248163

An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole.

Oystein Brorson1, Sverre-Henning A Brorson.   

Abstract

The susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole (TZ) was examined. The minimal bactericidal concentration (MBC) of TZ against the mobile spirochetes was >128 microg/ml at 37 degrees C in micro-oxic atmosphere when incubated for 14 days. TZ significantly reduced the conversion of mobile spirochetes to cystic forms during incubation. The MBC for older (10-months-old) cysts at 37 degrees C in a micro-oxic atmosphere was >0.5 microg/ml, but >0.125 microg/ml for young (1-day-old) cysts. Acridine orange staining, dark-field microscopy and transmission electron microscopy revealed that, when the concentration of TZ was > or = MBC, the contents of the cysts were partly degraded, core structures did not develop inside the young cysts, and the amount of RNA in these cysts decreased significantly. When cysts were exposed to TZ, both the spirochetal structures and core structures inside the cysts dissolved, and the production of blebs was significantly reduced. These observations may be valuable in the treatment of resistant infections caused by B. burgdorferi, and suggest that a combination of TZ and a macrolide antibiotic could eradicate both cystic and mobile forms of B. burgdorferi.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15248163

Source DB:  PubMed          Journal:  Int Microbiol        ISSN: 1139-6709            Impact factor:   2.479


  12 in total

Review 1.  Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Authors:  Daniel J Cameron; Lorraine B Johnson; Elizabeth L Maloney
Journal:  Expert Rev Anti Infect Ther       Date:  2014-07-30       Impact factor: 5.091

Review 2.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

3.  Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline.

Authors:  Øystein Brorson; Sverre-Henning Brorson; John Scythes; James MacAllister; Andrew Wier; Lynn Margulis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

4.  Interactions Between Ticks and Lyme Disease Spirochetes.

Authors:  Utpal Pal; Chrysoula Kitsou; Dan Drecktrah; Özlem Büyüktanir Yaş; Erol Fikrig
Journal:  Curr Issues Mol Biol       Date:  2020-12-08       Impact factor: 2.081

5.  Lyme disease: the next decade.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Infect Drug Resist       Date:  2011-01-07       Impact factor: 4.003

6.  Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi.

Authors:  Eva Sapi; Navroop Kaur; Samuel Anyanwu; David F Luecke; Akshita Datar; Seema Patel; Michael Rossi; Raphael B Stricker
Journal:  Infect Drug Resist       Date:  2011-05-03       Impact factor: 4.003

7.  Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia burgdorferi in Morgellons disease patients.

Authors:  Marianne J Middelveen; Cheryl Bandoski; Jennie Burke; Eva Sapi; Katherine R Filush; Yean Wang; Agustin Franco; Peter J Mayne; Raphael B Stricker
Journal:  BMC Dermatol       Date:  2015-02-12

Review 8.  Morgellons disease: a filamentous borrelial dermatitis.

Authors:  Marianne J Middelveen; Raphael B Stricker
Journal:  Int J Gen Med       Date:  2016-10-14

9.  Effect of RpoN, RpoS and LuxS Pathways on the Biofilm Formation and Antibiotic Sensitivity of Borrelia Burgdorferi.

Authors:  Eva Sapi; Priyanka A S Theophilus; Truc V Pham; Divya Burugu; David F Luecke
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-11-03

10.  Evidence of In Vivo Existence of Borrelia Biofilm in Borrelial Lymphocytomas.

Authors:  E Sapi; K Balasubramanian; A Poruri; J S Maghsoudlou; K M Socarras; A V Timmaraju; K R Filush; K Gupta; S Shaikh; P A S Theophilus; D F Luecke; A MacDonald; B Zelger
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.